Yu Sun

Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer

Yin Sun, Yu Sun, Lin Wang et al. · European Journal of Medicinal Chemistry · 2022 · 23 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Discovery of CZS-241: A Potent, Selective, and Orally Available Polo-Like Kinase 4 Inhibitor for the Treatment of Chronic Myeloid Leukemia

Yin Sun, Yanli Xue, Hongbing Liu et al. · Journal of Medicinal Chemistry · 2023 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study

Jingjing Yang, Yu Sun, Xingjia Li et al. · Frontiers in Oncology · 2022 · 14 citations · Full text

Medicine, Endocrinology, Radiology +17

Onjisaponin B (OB) is Neuroprotective During Cognitive Loss Through Immune-mediated and SIRT1 Pathways

Xinyu Li, Yu Sun, Yafen Wei et al. · Current Neurovascular Research · 2018 · 12 citations

Medicine, Neuroscience, Pharmacology +17

Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor

Yin Sun, Lin Wang, Yu Sun et al. · European Journal of Medicinal Chemistry · 2022 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14